Essential Medicines for Reproductive Health
Guiding Principles for Their Inclusion on National Medicines Lists
1 January 2006
| Manual
Overview
The objective of this guide is to provide background on the EML process and information on the importance of including reproductive health medicines on EMLs. It also provides tips for incorporating key reproductive health medicines into EMLs at the national level. It is intended to be used by reproductive health programme managers, national-level essential medicines committees, and those responsible for selecting, procuring, and ensuring the quality of reproductive health medicines.
WHO Team
Sexual and Reproductive Health and Research (SRH)
Editors
UNFPA, Program for Appropriate Technology in Health (PATH), World Health Organization
Number of pages
110
Copyright
Program for Appropriate Technology in Health (PATH), UNFPA, World Health Organization, 2006 - All rights reserved.